Profil
Einar Pontén is currently the Head-Business Development at Lipum AB since 2016.
Previously, he worked as the Managing Director at Merck SeQuant AB and as the Head-Research & Development at Anolytech AB. Dr. Pontén holds a doctorate degree from Umea Universitet.
Postes actifs de Einar Pontén
| Sociétés | Poste | Début |
|---|---|---|
| LIPUM AB | Corporate Officer/Principal | 01/12/2023 |
Anciens postes connus de Einar Pontén
| Sociétés | Poste | Fin |
|---|---|---|
Merck SeQuant AB
Merck SeQuant AB Medical SpecialtiesHealth Technology Provides liquid chromatography technology and other related products | Directeur Général | 02/01/2011 |
Anolytech AB
Anolytech AB Wholesale DistributorsDistribution Services Provides disinfection of livestock farming and food production solutions | Directeur Technique/Scientifique/R&D | - |
Formation de Einar Pontén
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Merck SeQuant AB
Merck SeQuant AB Medical SpecialtiesHealth Technology Provides liquid chromatography technology and other related products | Health Technology |
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anolytech AB
Anolytech AB Wholesale DistributorsDistribution Services Provides disinfection of livestock farming and food production solutions | Distribution Services |
Lipum AB
Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
















